Anti-obesity drugs will be 2024’s defining trend
Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development,…
Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development,…
Analysis of the key themes driving M&A activity reveals that personalization accounted for 2 pharmaceutical deals announced in Q1 2024,…
Analysis of the key themes driving M&A activity reveals that individualism & expression accounted for 2 pharmaceutical deals announced in…
A new study published in the British Medical Journal found potential in the use of psilocybin to treat depression, with…
Eli Lilly, the biggest pharma company by market value, is one of the main manufacturers of popular weight-loss drugs, including…
Analysis of the key themes driving M&A activity reveals that easy & affordable accounted for 3 pharmaceutical deals announced in…
Analysis of the key themes driving M&A activity reveals that health & wellness accounted for 11 pharmaceutical deals announced in…